23 C
New York
Sunday, June 14, 2026

Tag: spending

newssourceFORcompanyinformationcontent1marketreleases

Pressure Sensitive Adhesive Tapes Market worth $92.41 billion by 2030 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Aug. 15, 2025 /PRNewswire/ -- The report 'Pressure Sensitive Adhesive Tapes Market by Type (Single-Sided, Double-Sided), Adhesive Type (Acrylic, Rubber), Technology...

Orca Energy Group Inc. Announces Completion of Q2 2025 Interim Filings

ORCA ENERGY GROUP INC. ANNOUNCES COMPLETION OF Q2 2025 INTERIM FILINGS

U.S. Drone Land Surveying Market Expected to Reach $6.59 Billion By End Of 2033

MarketNewsUpdates News Commentary NEW YORK, Aug. 14, 2025 /PRNewswire/ -- The global drone market is poised to become one of the most important and fastest-growing...

Cellebrite Announces Second-Quarter 2025 Results

Thomas E. Hogan Named CEO

Gimme Credit: Corporate Bonds Stay Strong as U.S. Tariffs and Consumer Caution Test Market

NEW YORK, Aug. 14, 2025 /PRNewswire/ -- Gimme Credit's latest research shows that leading U.S. corporate issuers are holding firm against escalating tariffs and increasingly...

Battalion Oil Corporation Announces Second Quarter 2025 Financial and Operating Results

HOUSTON, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Battalion Oil Corporation (NYSE American: BATL, “Battalion” or the “Company”) today announced financial and operating results for the second quarter of 2025.

22nd Century Group Reports Second Quarter 2025 Financial Results

VLN® Early Adoption Commercial Activity Expands with Two Partner Brand Launches in Progress – Smoker Friendly and Pinnacle

Saudi Arabia Generic Drugs Market Outlook Report 2025-2033 | Government Cost-Cutting, Local Manufacturing, and Public Awareness Fuel Rapid Growth

The Saudi Arabia Generic Drugs Market is projected to expand from US$ 4.05 billion in 2024 to US$ 8.11 billion by 2033, registering a CAGR of 8.02%. This growth is driven by increased healthcare needs, government initiatives to reduce pharmaceutical spending, and rising awareness of affordable alternatives. Supportive regulatory policies by the Saudi Food and Drug Authority (SFDA) and investments in local manufacturing are further spurring market expansion. The market is also bolstered by growing demand due to the rising prevalence of chronic diseases and increased acceptance among consumers and healthcare professionals. 
The Saudi Arabia Generic Drugs Market is projected to expand from US$ 4.05 billion in 2024 to US$ 8.11 billion by 2033, registering a CAGR of 8.02%. This growth is driven by increased healthcare needs, government initiatives to reduce pharmaceutical spending, and rising awareness of affordable alternatives. Supportive regulatory policies by the Saudi Food and Drug Authority (SFDA) and investments in local manufacturing are further spurring market expansion. The market is also bolstered by growing demand due to the rising prevalence of chronic diseases and increased acceptance among consumers and healthcare professionals.

SM Investments H1 net income rises 6% to PHP42.6 billion

PASAY CITY, Philippines, Aug. 14, 2025 /PRNewswire/ -- SM Investments Corporation (SM Investments) posted a consolidated net income of PHP42.6 billion in the first...

SM Investments H1 net income rises 6% to PHP42.6 billion

PASAY CITY, Philippines, Aug. 14, 2025 /PRNewswire/ -- SM Investments Corporation (SM Investments) posted a consolidated net income of PHP42.6 billion in the first...

FRONTERA ANNOUNCES SECOND QUARTER 2025 RESULTS

Recorded $455.2 million in Net Loss Mainly due to Non-Cash Impairment Charges Related to its Interest in the Corentyne License and Ecuadorian Assets Increased Total...

FRONTERA ANNOUNCES SECOND QUARTER 2025 RESULTS

Recorded $455.2 million in Net Loss Mainly due to Non-Cash Impairment Charges Related to its Interest in the Corentyne License and Ecuadorian Assets Increased Total...

Unlocking Your Future: How Plug Power’s Latest Earnings Empower Women Investors

Hey there, fabulous finance queens! 💁‍♀️ Let’s dive into the world of hydrogen energy with a company that’s been making waves lately: Plug Power....

AlphaCur Gains Momentum in 2025 as a Leading Formula for Neuropathy Nerve Health Support

AlphaCur Introduces Ingredient-First Nerve Health Formula as Interest in Neuropathy Support and Long-Term Wellness Grows in 2025 
AlphaCur Introduces Ingredient-First Nerve Health Formula as Interest in Neuropathy Support and Long-Term Wellness Grows in 2025

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsSpending

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers